March 26, 2013 Interviewed By Steven E. Greer, MD
UCLA’s Dr. Edward Garon discusses anti-PD1 and anti-PD-L1 drugs treating NSCLC in early trials, with remarkable tumor response rates.
March 26, 2013 Interviewed By Steven E. Greer, MD
UCLA’s Dr. Edward Garon discusses anti-PD1 and anti-PD-L1 drugs treating NSCLC in early trials, with remarkable tumor response rates.